BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,658,150 | +34.7% | 8,790,000 | +37.1% | 0.00% | 0.0% |
| Q2 2023 | $6,426,026 | +127.8% | 6,410,000 | +144.2% | 0.00% | – |
| Q4 2022 | $2,820,694 | +1832.0% | 2,625,000 | +1697.9% | 0.00% | – |
| Q3 2022 | $146,000 | +121.2% | 146,000 | +121.2% | 0.00% | – |
| Q2 2022 | $66,000 | -87.6% | 66,000 | -87.5% | 0.00% | – |
| Q1 2022 | $531,000 | -13.1% | 530,000 | -9.6% | 0.00% | – |
| Q4 2021 | $611,000 | +6.3% | 586,000 | +0.9% | 0.00% | – |
| Q3 2021 | $575,000 | +147.8% | 581,000 | +151.5% | 0.00% | – |
| Q2 2021 | $232,000 | – | 231,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |